The impact of a successful treatment of HCV on glyco-metabolic control in diabetic patients

Carla Carnovale, Marta Gentili, Carlo Magni, Faizan Mazhar, Giulia Mosini, Emilio Clementi, Sonia Radice
2019 Antiviral Therapy  
We read with interest the review by Adinolfi et al highlighting the need to evaluate all persons with Hepatitis C Virus (HCV) infection for diabetes, in view of extrahepatic benefits of viral eradication, the reduced risk of diabetic complications and improved glyco-metabolic control in HCV-infected patients [1].
doi:10.3851/imp3300 pmid:30835253 fatcat:ykmlqvih4bgpvo6uyyixmbj67a